Charles River Laboratories International, Inc. (CRL)
167.57
-0.65
(-0.39%)
USD |
NYSE |
Apr 07, 12:21
Charles River Laboratories International EPS Diluted (Quarterly) : -5.619 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 2.990 |
| Centene Corp. | -2.240 |
| Johnson & Johnson | 2.098 |
| Molina Healthcare, Inc. | -3.137 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -276.29M |
| Revenue (Quarterly) | 994.23M |
| Total Expenses (Quarterly) | 1.271B |
| Enterprise Value | 10.74B |
| Gross Profit Margin (Quarterly) | 30.96% |
| Profit Margin (Quarterly) | -27.79% |
| Earnings Yield | -1.82% |
| Operating Earnings Yield | 6.22% |
| Normalized Earnings Yield | 2.263 |